Print this page    •   Back to Web version of article

Prevention/Epidemiology
USAID, PEPFAR Brief Addresses Hormonal Contraception Use, HIV Risk

September 16, 2013

"While evidence of a tie between some injectable hormonal contraceptives and an increased risk of HIV acquisition remains incomplete, that potential risk must be balanced against the life-saving benefits of preventing unintended pregnancy, a brief [.pdf] from USAID's Office of Population and Reproductive Health says," the Center for Global Health Policy's "Science Speaks" blog reports. The brief, prepared in collaboration with PEPFAR, "concludes that the search for conclusive evidence of acquisition risk, as well as for safe, affordable technologies to prevent both unintended pregnancy and HIV acquisition, continues," the blog notes (Barton, 9/13).

Back to other news for September 2013


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/72714/usaid-pepfar-brief-addresses-hormonal-contraceptio.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.